ArticleFrontiers in oncology2022

The Role of the CDK4/6 Inhibitor Ribociclib in Locally Advanced and Oligometastatic Hormone Receptor Positive, Her2 Negative, Advanced Breast Cancer: Case Series and Review of the Literature.

Andrea Botticelli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.